CD44 and head and neck squamous cell carcinoma: We have demonstrated that ∆Np63 is able to drive the expression of the HA synthase gene HAS3 and the HA receptor CD44, thus favouring the HA/CD44‐mediated oncogenic signaling in HNSCC.